Visualizando por Autor SIGNORETTI, SABINA
Mostrando reg. 1 a 11 de 11
| Fecha de Publicación | Título | Autor(s) |
| 2015 | Differential Expression of PD-L1 between Primary and Metastatic Sites in Clear-Cell Renal Cell Carcinoma. | CALLEA, MARCELLA; ALBIGES, LAURENCE; Mampta Gupta, etc. |
| 2017 | Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model | DE VELASCO, GUILLERMO; CULHANE, AEDÍN C.; André Poisl Fay, etc. |
| 2019 | Mutations and Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma | NASSAR, AMIN H; HAMIEH, LANA; GRAY, KATHRYN P., etc. |
| 2016 | Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell Carcinoma | DE VELASCO, GUILLERMO; GRAY, KATHRYN P.; HAMIEH, LANA, etc. |
| 2016 | Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell Carcinoma | DE VELASCO, GUILLERMO; GRAY, KATHRYN P.; HAMIEH, LANA, etc. |
| 2016 | Phase 2 Study of Bevacizumab and Temsirolimus After VEGFR TKI in Metastatic Renal Cell Carcinoma | MAHONEY, KATHLEEN M.; JACOBUS, SUSANNA; BHATT, RUPAL S., etc. |
| 2015 | Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker study | André Poisl Fay; SIGNORETTI, SABINA; CALLEA, MARCELLA, etc. |
| 2015 | Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker study | André Poisl Fay; SIGNORETTI, SABINA; CALLEA, MARCELLA, etc. |
| 2018 | The Clinical Activity of PD-1/PD-L1 inhibitors in Metastatic Non-Clear Cell Renal Cell Carcinoma | MCKAY, RANA R.; BOSSÉ, DOMINICK; XIE, WANLING, etc. |
| 2018 | The Clinical Activity of PD-1/PD-L1 inhibitors in Metastatic Non-Clear Cell Renal Cell Carcinoma | MCKAY, RANA R.; BOSSÉ, DOMINICK; XIE, WANLING, etc. |
| 2016 | Whole-Exome Sequencing in Two Extreme Phenotypes of Response to VEGF-Targeted Therapies in Patients With Metastatic Clear Cell Renal Cell Carcinoma | André Poisl Fay; DEVELASCO, GUILLERMO; Thai Ho, etc. |
